RNA methylation and cellular response to oxidative stress-promoting anticancer agents

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.
   PubMed Web of Science ®Google Scholar
• Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer. 2004;4:737–747.
   PubMed Web of Science ®Google Scholar
• Kachalaki S, Ebrahimi M, Mohamed Khosroshahi L, et al. Cancer chemoresistance; biochemical and molecular aspects: a brief overview. Eur J Pharm Sci off J Eur Fed Pharm Sci. 2016;89:20–30.
   PubMed Web of Science ®Google Scholar
• Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20:651–668.
   PubMed Web of Science ®Google Scholar
• Guo L, Lee Y-T, Zhou Y, et al. Targeting epigenetic regulatory machinery to overcome cancer therapy resistance. Semin Cancer Biol. 2022;83:487–502.
   PubMed Web of Science ®Google Scholar
• Mani DR, Krug K, Zhang B, et al. Cancer proteogenomics: current impact and future prospects. Nat Rev Cancer. 2022;22:298–313.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Q, Zhou L, et al. Cancer drug resistance: redox resetting renders a way. Oncotarget. 2016;7:42740–42761.
   PubMedGoogle Scholar
• Zhang L, Lu Q, Chang C. Epigenetics in Health and Disease. In: Chang C Lu Q editors. Epigenetics Allergy Autoimmune [Internet]. Singapore: Springer Singapore; 2020pp. 3–55. cited 2022 Jul 11. Available from. https://link.springer.co
   Google Scholar
• Machnicka MA, Milanowska K, Osman Oglou O, et al. MODOMICS: a database of RNA modification pathways—2013 update. Nucleic Acids Res. 2012;41:D262–267.
   PubMed Web of Science ®Google Scholar
• Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20:303–322.
   PubMed Web of Science ®Google Scholar
• Song H, Liu D, Dong S, et al. Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications. Signal Transduct Target Ther. 2020;5:193.
   PubMed Web of Science ®Google Scholar
• Phizicky EM, Hopper AK. tRNA biology charges to the front. Genes Dev. 2010;24:1832–1860.
   PubMed Web of Science ®Google Scholar
• Nachtergaele S, He C. The emerging biology of RNA post-transcriptional modifications. RNA Biol. 2017;14:156–163.
   PubMed Web of Science ®Google Scholar
• Lecointe F, Simos G, Sauer A, et al. Characterization of Yeast Protein Deg1 as Pseudouridine Synthase (Pus3) Catalyzing the Formation of Ψ38 and Ψ39 in tRNA Anticodon Loop. J Biol Chem. 1998;273:1316–1323.
   PubMed Web of Science ®Google Scholar
• Bjork GR. A primordial tRNA modification required for the evolution of life? EMBO J. 2001;20:231–239.
   PubMed Web of Science ®Google Scholar
• Gerber AP, Keller W. An Adenosine Deaminase that Generates Inosine at the Wobble Position of tRnas. Science. 1999;286:1146–1149.
   PubMed Web of Science ®Google Scholar
• Dihanich ME, Najarian D, Clark R, et al. Isolation and characterization of MOD5, a gene required for isopentenylation of cytoplasmic and mitochondrial tRnas of Saccharomyces cerevisiae. Mol Cell Biol. 1987;7:177–184.
   PubMed Web of Science ®Google Scholar
• Sloan KE, Warda AS, Sharma S, et al. Tuning the ribosome: the influence of rRNA modification on eukaryotic ribosome biogenesis and function. RNA Biol. 2017;14:1138–1152.
   PubMed Web of Science ®Google Scholar
• Ben-Shem A, Garreau de Loubresse N, Melnikov S, et al. The Structure of the Eukaryotic Ribosome at 3.0 Å Resolution. Science. 2011;334:1524–1529.
   PubMed Web of Science ®Google Scholar
• Decatur WA, Fournier MJ. rRNA modifications and ribosome function. Trends Biochem Sci. 2002;27:344–351.
   PubMed Web of Science ®Google Scholar
• Krogh N, Jansson MD, Häfner SJ, et al. Profiling of 2′- O -Me in human rRNA reveals a subset of fractionally modified positions and provides evidence for ribosome heterogeneity. Nucleic Acids Res. 2016;44:7884–7895.
   PubMed Web of Science ®Google Scholar
• Birkedal U, Christensen-Dalsgaard M, Krogh N, et al. Profiling of Ribose Methylations in RNA by High-Throughput Sequencing. Angew Chem Int Ed. 2015;54: 451–455.
   PubMed Web of Science ®Google Scholar
• Maden BEH, Corbett ME, Heeney PA, et al. Classical and novel approaches to the detection and localization of the numerous modified nucleotides in eukaryotic ribosomal RNA. Biochimie. 1995;77:22–29.
   PubMed Web of Science ®Google Scholar
• Bakin A, Ofengand J. Four newly located pseudouridylate residues in Escherichia coli 23S ribosomal RNA are all at the peptidyltransferase center: analysis by the application of a new sequencing technique. Biochemistry. 1993;32:9754–9762.
   PubMed Web of Science ®Google Scholar
• King TH, Liu B, McCully RR, et al. Ribosome Structure and Activity are Altered in Cells Lacking snoRnps that Form Pseudouridines in the Peptidyl Transferase Center. Mol Cell. 2003;11:425–435.
   PubMed Web of Science ®Google Scholar
• Liang X, Liu Q, Fournier MJ. Loss of rRNA modifications in the decoding center of the ribosome impairs translation and strongly delays pre-rRNA processing. RNA. 2009;15:1716–1728.
   PubMed Web of Science ®Google Scholar
• Baxter-Roshek JL, Petrov AN, Dinman JD. Optimization of Ribosome Structure and Function by rRNA Base Modification. In: Preiss T, editor. PLoS ONE. Vol. 2. 2007. p. e174.
   Google Scholar
• Liang X, Liu Q, Fournier MJ. rRNA Modifications in an Intersubunit Bridge of the Ribosome Strongly Affect Both Ribosome Biogenesis and Activity. Mol Cell. 2007;28:965–977.
   PubMed Web of Science ®Google Scholar
• Baudin-Baillieu A, Fabret C, Liang X, et al. Nucleotide modifications in three functionally important regions of the Saccharomyces cerevisiae ribosome affect translation accuracy. Nucleic Acids Res. 2009;37:7665–7677.
   PubMed Web of Science ®Google Scholar
• Andreassi C, Crerar H, Riccio A. Post-transcriptional Processing of mRNA in Neurons: the Vestiges of the RNA World Drive Transcriptome Diversity. Front Mol Neurosci. 2018;11:304.
   PubMed Web of Science ®Google Scholar
• Furuichi Y. Discovery of m7G-cap in eukaryotic mRnas. Proc Jpn Acad Ser B. 2015;91:394–409.
   PubMed Web of Science ®Google Scholar
• Carlile TM, Rojas-Duran MF, Zinshteyn B, et al. Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature. 2014;515:143–146.
   PubMed Web of Science ®Google Scholar
• Lovejoy AF, Riordan DP, Brown PO. Transcriptome-Wide Mapping of Pseudouridines: pseudouridine Synthases Modify Specific mRnas in S. cerevisiae. In: Preiss T, editor. PLoS ONE. Vol. 9. 2014. p. e110799.
   Google Scholar
• Li X, Zhu P, Ma S, et al. Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome. Nat Chem Biol. 2015;11:592–597.
   PubMed Web of Science ®Google Scholar
• He L, Li H, Wu A, et al. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.
   PubMed Web of Science ®Google Scholar
• Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A. 1974;71:3971–3975.
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, He C. Reversible RNA adenosine methylation in biological regulation. Trends Genet. 2013;29:108–115.
   PubMed Web of Science ®Google Scholar
• Roundtree IA, Evans ME, Pan T, et al. Dynamic RNA Modifications in Gene Expression Regulation. Cell. 2017;169:1187–1200.
   PubMed Web of Science ®Google Scholar
• Liu J, Yue Y, Han D, et al. A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93–95.
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885–887.
   PubMed Web of Science ®Google Scholar
• Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117–120.
   PubMed Web of Science ®Google Scholar
• Du H, Zhao Y, He J, et al. YTHDF2 destabilizes m6a-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex. Nat Commun. 2016;7:12626.
   PubMed Web of Science ®Google Scholar
• Meyer KD, Patil DP, Zhou J, et al. 5′ UTR m6a Promotes Cap-Independent Translation. Cell. 2015;163:999–1010.
   PubMed Web of Science ®Google Scholar
• Dominissini D, Nachtergaele S, Moshitch-Moshkovitz S, et al. The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA. Nature. 2016;530:441–446.
   PubMed Web of Science ®Google Scholar
• Zhou H, Kimsey IJ, Nikolova EN, et al. M1a and m1g disrupt A-RNA structure through the intrinsic instability of Hoogsteen base pairs. Nat Struct Mol Biol. 2016;23:803–810.
   PubMed Web of Science ®Google Scholar
• Xue C, Zhao Y, Li L. Advances in RNA cytosine-5 methylation: detection, regulatory mechanisms, biological functions and links to cancer. Biomark Res. 2020;8:43.
   PubMed Web of Science ®Google Scholar
• Sharma S, Yang J, Watzinger P, et al. Yeast Nop2 and Rcm1 methylate C2870 and C2278 of the 25S rRNA, respectively. Nucleic Acids Res. 2013;41:9062–9076.
   PubMed Web of Science ®Google Scholar
• Schosserer M, Minois N, Angerer TB, et al. Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan. Nat Commun. 2015;6:6158.
   PubMed Web of Science ®Google Scholar
• Aschenbrenner J, Marx A. Direct and site-specific quantification of RNA 2′-O-methylation by PCR with an engineered DNA polymerase. Nucleic Acids Res. 2016;44:3495–3502.
   PubMed Web of Science ®Google Scholar
• Erales J, Marchand V, Panthu B, et al. Evidence for rRNA 2′-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes. Proc Natl Acad Sci. 2017;114:12934–12939.
   PubMed Web of Science ®Google Scholar
• Basu A, Das P, Chaudhuri S, et al. Requirement of rRNA Methylation for 80S Ribosome Assembly on a Cohort of Cellular Internal Ribosome Entry Sites. Mol Cell Biol. 2011;31:4482–4499.
   PubMed Web of Science ®Google Scholar
• Jiang X, Liu B, Nie Z, et al. The role of m6a modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.
   PubMed Web of Science ®Google Scholar
• Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6a RNA methylomes revealed by m6a-seq. Nature. 2012;485:201–206.
   PubMed Web of Science ®Google Scholar
• Meyer KD, Saletore Y, Zumbo P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3’ UTRs and near stop codons. Cell. 2012;149:1635–1646.
   PubMed Web of Science ®Google Scholar
• Zhang C, Chen Y, Sun B, et al. M6a modulates haematopoietic stem and progenitor cell specification. Nature. 2017;549:273–276.
   PubMed Web of Science ®Google Scholar
• Lv J, Zhang Y, Gao S, et al. Endothelial-specific m6a modulates mouse hematopoietic stem and progenitor cell development via Notch signaling. Cell Res. 2018;28:249–252.
   PubMed Web of Science ®Google Scholar
• Wang H, Zuo H, Liu J, et al. Loss of YTHDF2-mediated m6a-dependent mRNA clearance facilitates hematopoietic stem cell regeneration. Cell Res. 2018;28:1035–1038.
   PubMed Web of Science ®Google Scholar
• Gao Y, Vasic R, Song Y, et al. M6a Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development. Immunity. 2020;52:1007–1021.e8.
   PubMed Web of Science ®Google Scholar
• Ma C, Chang M, Lv H, et al. RNA m6a methylation participates in regulation of postnatal development of the mouse cerebellum. Genome Biol. 2018;19:68.
   PubMed Web of Science ®Google Scholar
• Li L, Zang L, Zhang F, et al. Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Hum Mol Genet. 2017;26:2398–2411.
   PubMed Web of Science ®Google Scholar
• Zhuang M, Li X, Zhu J, et al. The m6a reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression. Nucleic Acids Res. 2019;47:4765–4777.
   PubMed Web of Science ®Google Scholar
• Weng Y-L, Wang X, An R, et al. Epitranscriptomic m6a Regulation of Axon Regeneration in the Adult Mammalian Nervous System. Neuron. 2018;97:313–325.e6.
   PubMed Web of Science ®Google Scholar
• Xhemalce B, Robson SC, Kouzarides T. Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing. Cell. 2012;151:278–288.
   PubMed Web of Science ®Google Scholar
• Cheray M, Etcheverry A, Jacques C, et al. Cytosine methylation of mature microRnas inhibits their functions and is associated with poor prognosis in glioblastoma multiforme. Mol Cancer. 2020;19:36.
   PubMed Web of Science ®Google Scholar
• Alarcón CR, Lee H, Goodarzi H, et al. N6-methyladenosine marks primary microRnas for processing. Nature. 2015;519:482–485.
   PubMed Web of Science ®Google Scholar
• Berulava T, Rahmann S, Rademacher K, et al. N6-Adenosine Methylation in MiRnas. In: Antoniewski C, editor. PLOS ONE. Vol. 10. 2015. p. e0118438.
   Google Scholar
• Zhou Y, Kong Y, Fan W, et al. Principles of RNA methylation and their implications for biology and medicine. Biomed Pharmacother. 2020;131:110731.
   PubMed Web of Science ®Google Scholar
• Wu J, Guo X, Wen Y, et al. N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology. Front Cell Dev Biol. 2021;9:709299.
   PubMed Web of Science ®Google Scholar
• Zhang C, Cui H, Huang C, et al. Interactions of circRnas with methylation: an important aspect of circRNA biogenesis and function (Review). Mol Med Rep. 2022;25:169.
   PubMed Web of Science ®Google Scholar
• Pastore B, Hertz HL, Price IF, et al. Pre-piRNA trimming and 2′-O-methylation protect piRnas from 3′ tailing and degradation in C. elegans. Cell Rep. 2021;36:109640.
   PubMed Web of Science ®Google Scholar
• Goh YT, Koh CWQ, Sim DY, et al. METTL4 catalyzes m6am methylation in U2 snRNA to regulate pre-mRNA splicing. Nucleic Acids Res. 2020;48:9250–9261.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997;82:291–295.
   PubMed Web of Science ®Google Scholar
• Shen Z, Wu W, Hazen SL. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry. 2000;39:5474–5482.
   PubMed Web of Science ®Google Scholar
• Hofer T, Badouard C, Bajak E, et al. Hydrogen peroxide causes greater oxidation in cellular RNA than in DNA. Biol Chem. 2005;386:333–337.
   PubMed Web of Science ®Google Scholar
• Liu M, Gong X, Alluri RK, et al. Characterization of RNA damage under oxidative stress in Escherichia coli. Biol Chem. 2012;393:123–132.
   PubMed Web of Science ®Google Scholar
• Chen X, Yu H, Li Z, et al. Oxidative RNA Damage in the Pathogenesis and Treatment of Type 2 Diabetes. Front Physiol. 2022;13:725919.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chock PB, Stadtman ER. Oxidized messenger RNA induces translation errors. Proc Natl Acad Sci, USA. 2007;104:66–71.
   PubMed Web of Science ®Google Scholar
• Willi J, Küpfer P, Evéquoz D, et al. Oxidative stress damages rRNA inside the ribosome and differentially affects the catalytic center. Nucleic Acids Res. 2018;46:1945–1957.
   PubMed Web of Science ®Google Scholar
• Leiva LE, Pincheira A, Elgamal S, et al. Modulation of Escherichia coli Translation by the Specific Inactivation of tRnagly Under Oxidative Stress. Front Genet. 2020;11:856.
   PubMedGoogle Scholar
• Estevez M, Valesyan S, Jora M, et al. Oxidative Damage to RNA is Altered by the Presence of Interacting Proteins or Modified Nucleosides. Front Mol Biosci. 2021;8:697149.
   PubMed Web of Science ®Google Scholar
• Baldridge KC, Contreras LM. Functional implications of ribosomal RNA methylation in response to environmental stress. Crit Rev Biochem Mol Biol. 2014;49:69–89.
   PubMed Web of Science ®Google Scholar
• Borek E, Srinivasan PR. The Methylation of Nucleic Acids. Annu Rev Biochem. 1966;35:275–298.
   Web of Science ®Google Scholar
• Wilkinson E, Cui Y-H, He Y-Y. Context-Dependent Roles of RNA Modifications in Stress Responses and Diseases. Int J Mol Sci. 2021;22:1949.
   PubMed Web of Science ®Google Scholar
• Cao SS, Kaufman RJ. Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease. Antioxid Redox Signal. 2014;21:396–413.
   PubMed Web of Science ®Google Scholar
• Zhang H, Gong W, Wu S, et al. Hsp70 in Redox Homeostasis. Cells. 2022;11:829.
   PubMed Web of Science ®Google Scholar
• Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21:363–383.
   PubMed Web of Science ®Google Scholar
• Juan CA, Pérez de la Lastra JM, Plou FJ, et al. The Chemistry of Reactive Oxygen Species (ROS) Revisited: outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. Int J Mol Sci. 2021;22:4642.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang X, Cueto R, et al. Biochemical basis and metabolic interplay of redox regulation. Redox Biol. 2019;26:101284.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kim JJ, Miller KM. Emerging roles of RNA modifications in genome integrity. Brief Funct Genomics. 2021;20:106–112.
   PubMed Web of Science ®Google Scholar
• Samet JM, Wages PA. Oxidative stress from environmental exposures. Curr Opin Toxicol. 2018;7:60–66.
   PubMedGoogle Scholar
• Sies H. Oxidative eustress: on constant alert for redox homeostasis. Redox Biol. 2021;41:101867.
   PubMed Web of Science ®Google Scholar
• Agarwalla S, Kealey JT, Santi DV, et al. Characterization of the 23 S Ribosomal RNA m5u1939 Methyltransferase from Escherichia coli. J Biol Chem. 2002;277:8835–8840.
   PubMed Web of Science ®Google Scholar
• Agarwalla S, Stroud RM, Gaffney BJ. Redox Reactions of the Iron-Sulfur Cluster in a Ribosomal RNA Methyltransferase, RumA. J Biol Chem. 2004;279:34123–34129.
   PubMed Web of Science ®Google Scholar
• Kyuma T, Kimura S, Hanada Y, et al. Ribosomal RNA methyltransferases contribute to Staphylococcus aureus virulence. FEBS J. 2015;282:2570–2584.
   PubMed Web of Science ®Google Scholar
• Kyuma T, Kizaki H, Ryuno H, et al. 16S rRNA methyltransferase KsgA contributes to oxidative stress resistance and virulence in Staphylococcus aureus. Biochimie. 2015;119:166–174.
   PubMed Web of Science ®Google Scholar
• Begley TJ, Rosenbach AS, Ideker T, et al. Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping. Mol Cancer Res MCR. 2002;1:103–112.
   PubMed Web of Science ®Google Scholar
• Begley TJ, Rosenbach AS, Ideker T, et al. Hot Spots for Modulating Toxicity Identified by Genomic Phenotyping and Localization Mapping. Mol Cell. 2004;16:117–125.
   PubMed Web of Science ®Google Scholar
• Begley U, Dyavaiah M, Patil A, et al. Trm9-catalyzed tRNA modifications link translation to the DNA damage response. Mol Cell. 2007;28:860–870.
   PubMed Web of Science ®Google Scholar
• Chan CTY, Pang YLJ, Deng W, et al. Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins. Nat Commun. 2012;3:937.
   PubMed Web of Science ®Google Scholar
• Golovina AY, Sergiev PV, Golovin AV, et al. The yfiC gene of E. coli encodes an adenine-N6 methyltransferase that specifically modifies A37 of tRNA 1 val (cmo 5 UAC). RNA. 2009;15:1134–1141.
   PubMed Web of Science ®Google Scholar
• Osterman IA, Sergiev PV, Tsvetkov PO, et al. Methylated 23S rRNA nucleotide m2g1835 of Escherichia coli ribosome facilitates subunit association. Biochimie. 2011;93:725–729.
   PubMed Web of Science ®Google Scholar
• Jaroensuk J, Atichartpongkul S, Chionh YH, et al. Methylation at position 32 of tRNA catalyzed by TrmJ alters oxidative stress response in Pseudomonas aeruginosa. Nucleic Acids Res. 2016;44:10834–10848.
   PubMed Web of Science ®Google Scholar
• Dedon PC, Begley TJ. A system of RNA modifications and biased codon use controls cellular stress response at the level of translation. Chem Res Toxicol. 2014;27:330–337.
   PubMed Web of Science ®Google Scholar
• Barroso M, Florindo C, Kalwa H, et al. Inhibition of Cellular Methyltransferases Promotes Endothelial Cell Activation by Suppressing Glutathione Peroxidase 1 Protein Expression. J Biol Chem. 2014;289:15350–15362.
   PubMed Web of Science ®Google Scholar
• Schaefer M, Pollex T, Hanna K, et al. RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage. Genes Dev. 2010;24:1590–1595.
   PubMed Web of Science ®Google Scholar
• Schaefer M, Lyko F. Solving the Dnmt2 enigma. Chromosoma. 2010;119:35–40.
   PubMed Web of Science ®Google Scholar
• Goll MG, Kirpekar F, Maggert KA, et al. Methylation of tRnaasp by the DNA methyltransferase homolog Dnmt2. Science. 2006;311:395–398.
   PubMed Web of Science ®Google Scholar
• Mytych J, Lewinska A, Bielak-Zmijewska A, et al. Nanodiamond-mediated impairment of nucleolar activity is accompanied by oxidative stress and DNMT2 upregulation in human cervical carcinoma cells. Chem Biol Interact. 2014;220:51–63.
   PubMed Web of Science ®Google Scholar
• Chellamuthu A, Gray SG. The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer. Cells. 2020;9:1758.
   PubMed Web of Science ®Google Scholar
• Blanco S, Dietmann S, Flores JV, et al. Aberrant methylation of t RNA s links cellular stress to neuro‐developmental disorders. EMBO J. 2014;33:2020–2039.
   PubMed Web of Science ®Google Scholar
• Ivanov P, Emara MM, Villen J, et al. Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell. 2011;43:613–623.
   PubMed Web of Science ®Google Scholar
• Hertz R, Tovy A, Kirschenbaum M, et al. The Entamoeba histolytica Dnmt2 homolog (Ehmeth) confers resistance to nitrosative stress. Eukaryot Cell. 2014;13:494–503.
   PubMedGoogle Scholar
• Jeltsch A, Ehrenhofer-Murray A, Jurkowski TP, et al. Mechanism and biological role of Dnmt2 in Nucleic Acid Methylation. RNA Biol. 2017;14:1108–1123.
   PubMed Web of Science ®Google Scholar
• Dewe JM, Fuller BL, Lentini JM, et al. TRMT1-Catalyzed tRNA Modifications are Required for Redox Homeostasis to Ensure Proper Cellular Proliferation and Oxidative Stress Survival. Mol Cell Biol. 2017;37:e00214–17.
   PubMed Web of Science ®Google Scholar
• Endres L, Rose RE, Doyle F, et al. 2’-O-ribose methylation of transfer RNA promotes recovery from oxidative stress in Saccharomyces cerevisiae. In: Preiss T, editor. PLOS ONE. Vol. 15. 2020. p. e0229103.
   Google Scholar
• Trixl L, Amort T, Wille A, et al. RNA cytosine methyltransferase Nsun3 regulates embryonic stem cell differentiation by promoting mitochondrial activity. Cell Mol Life Sci. 2018;75:1483–1497.
   PubMed Web of Science ®Google Scholar
• Cosentino C, Toivonen S, Diaz Villamil E, et al. Pancreatic β-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetes. Nucleic Acids Res. 2018;46:10302–10318.
   PubMed Web of Science ®Google Scholar
• Rashad S, Han X, Sato K, et al. The stress specific impact of ALKBH1 on tRNA cleavage and tiRNA generation. RNA Biol. 2020;17:1092–1103.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wan J, Gao X, et al. Dynamic m(6)a mRNA methylation directs translational control of heat shock response. Nature. 2015;526:591–594.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu Z, Yi J, et al. The tRNA methyltransferase NSun2 stabilizes p16ink4 mRNA by methylating the 3′-untranslated region of p16. Nat Commun. 2012;3:712.
   PubMed Web of Science ®Google Scholar
• Cai X, Hu Y, Tang H, et al. RNA methyltransferase NSUN2 promotes stress-induced HUVEC senescence. Oncotarget. 2016;7:19099–19110.
   PubMedGoogle Scholar
• Ciciliot S, Fadini G. Modulation of Obesity and Insulin Resistance by the Redox Enzyme and Adaptor Protein p66shc. Int J Mol Sci. 2019;20:985.
   PubMed Web of Science ®Google Scholar
• Yuan S, Tang H, Xing J, et al. Methylation by NSun2 represses the levels and function of microRNA 125b. Mol Cell Biol. 2014;34:3630–3641.
   PubMed Web of Science ®Google Scholar
• Lu C, Zhou D, Wang Q, et al. Crosstalk of MicroRnas and Oxidative Stress in the Pathogenesis of Cancer. Oxid Med Cell Longev. 2020;2020:1–13.
   Web of Science ®Google Scholar
• Zhao T-X, Wang J-K, Shen L-J, et al. Increased m6a RNA modification is related to the inhibition of the Nrf2-mediated antioxidant response in di-(2-ethylhexyl) phthalate-induced prepubertal testicular injury. Environ Pollut. 2020;259:113911.
   PubMed Web of Science ®Google Scholar
• Arumugam T, Ghazi T, Chuturgoon AA. Fumonisin B1 alters global m6a RNA methylation and epigenetically regulates Keap1-Nrf2 signaling in human hepatoma (HepG2) cells. Arch Toxicol. 2021;95:1367–1378.
   PubMed Web of Science ®Google Scholar
• Moldogazieva NT, Lutsenko SV, Terentiev AA. Reactive Oxygen and Nitrogen Species–Induced Protein Modifications: implication in Carcinogenesis and Anticancer Therapy. Cancer Res. 2018;78:6040–6047.
   PubMed Web of Science ®Google Scholar
• Li Q, Li X, Tang H, et al. NSUN2-Mediated m5c Methylation and METTL3/METTL14-Mediated m6a Methylation Cooperatively Enhance p21 Translation: nSUN2 and METTL3/METTL14 R EGULATE p21 T RANSLATION. J Cell Biochem. 2017;118:2587–2598.
   PubMed Web of Science ®Google Scholar
• Chen W, Sun Z, Wang X-J, et al. Direct Interaction between Nrf2 and p21cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response. Mol Cell. 2009;34:663–673.
   PubMed Web of Science ®Google Scholar
• Zhao F, Xu Y, Gao S, et al. METTL3-dependent RNA m6a dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events. Mol Neurodegener. 2021;16:70.
   PubMed Web of Science ®Google Scholar
• Gonchar O, Mankovska I. Hypoxia/Reoxygenation modulates Oxidative Stress Level and Antioxidative Potential in Lung Mitochondria: possible participation of P53 and NF-KB Target Proteins. Arch Pulmonol Respir Care. 2017;3:035–043.
   Google Scholar
• Song H, Feng X, Zhang H, et al. METTL3 and ALKBH5 oppositely regulate m 6 a modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy. 2019;15:1419–1437.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang J, Ma Y, et al. WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6a modification of ATF4 mRNA. Aging. 2021;13:11135–11149.
   PubMedGoogle Scholar
• Pang P, Qu Z, Yu S, et al. Mettl14 Attenuates Cardiac Ischemia/Reperfusion Injury by Regulating Wnt1/β-Catenin Signaling Pathway. Front Cell Dev Biol. 2021;9:762853.
   PubMed Web of Science ®Google Scholar
• Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3.
   PubMed Web of Science ®Google Scholar
• Guo Y, Song W, Yang Y. Inhibition of ALKBH5 ‐mediated m 6 a modification of PPARG mRNA alleviates H/R‐induced oxidative stress and apoptosis in placenta trophoblast. Environ Toxicol. 2022;37:910–924.
   PubMed Web of Science ®Google Scholar
• Anders M, Chelysheva I, Goebel I, et al. Dynamic m 6 a methylation facilitates mRNA triaging to stress granules. Life Sci Alliance. 2018;1:e201800113.
   PubMed Web of Science ®Google Scholar
• Protter DSW, Parker R. Principles and Properties of Stress Granules. Trends Cell Biol. 2016;26:668–679.
   PubMed Web of Science ®Google Scholar
• Fu Y, Zhuang X. M6a-binding YTHDF proteins promote stress granule formation. Nat Chem Biol. 2020;16:955–963.
   PubMed Web of Science ®Google Scholar
• Du YD, Guo WY, Han CH, et al. N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation. Cell Death Dis. 2021;12:442.
   PubMed Web of Science ®Google Scholar
• Qu T, Mou Y, Dai J, et al. Changes and relationship of N6-methyladenosine modification and long non-coding RNAs in oxidative damage induced by cadmium in pancreatic β-cells. Toxicol Lett. 2021;343:56–66.
   PubMed Web of Science ®Google Scholar
• Su Q, Chen N, Tang J, et al. Paraquat-induced oxidative stress regulates N6-methyladenosine (m6a) modification of long noncoding RNAs in Neuro-2a cells. Ecotoxicol Environ Saf. 2022;237:113503.
   PubMed Web of Science ®Google Scholar
• Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Lett. 2017;387:95–105.
   PubMed Web of Science ®Google Scholar
• Marengo B, Nitti M, Furfaro AL, et al. Redox Homeostasis and Cellular Antioxidant Systems: crucial Players in Cancer Growth and Therapy. Oxid Med Cell Longev. 2016;2016:6235641.
   PubMed Web of Science ®Google Scholar
• Perillo B, Di Donato M, Pezone A, et al. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52:192–203.
   PubMed Web of Science ®Google Scholar
• Safford SE, Oberley TD, Urano M, et al. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res. 1994;54:4261–4265.
   PubMed Web of Science ®Google Scholar
• Beehler BC, Przybyszewski J, Box HB, et al. Formation of 8-hydroxydeoxyguanosine within DNA of mouse keratinocytes exposed in culture to UVB and H2O2. Carcinogenesis. 1992;13:2003–2007.
   PubMed Web of Science ®Google Scholar
• Lee JK, Edderkaoui M, Truong P, et al. NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases. Gastroenterol. 2007;133:1637–1648.
   PubMed Web of Science ®Google Scholar
• Seo JM, Cho KJ, Kim EY, et al. Up-regulation of BLT2 is critical for the survival of bladder cancer cells. Exp Mol Med. 2011;43:129–137.
   PubMed Web of Science ®Google Scholar
• Cheng C-W, Kuo C-Y, Fan C-C, et al. Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species. Cell Death Dis. 2013;4:e681.
   PubMed Web of Science ®Google Scholar
• Cao L, Chen X, Xiao X, et al. Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways. Int J Oncol. 2016;49:735–743.
   PubMed Web of Science ®Google Scholar
• Lien G-S, Wu W, Bien M-Y, et al. Epidermal growth factor stimulates nuclear factor-κB activation and heme oxygenase-1 expression via c-Src, NADPH oxidase, PI3K, and Akt in human colon cancer cells. PLoS ONE. 2014;9:e104891.
   PubMed Web of Science ®Google Scholar
• Varghese SS, Sunil PM, Madhavan RN. Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma: an immunohistochemical study. Cancer Biomark Sect Dis Markers. 2010;8:155–160.
   PubMed Web of Science ®Google Scholar
• Aydin E, Johansson J, Nazir FH, et al. Role of NOX2-Derived Reactive Oxygen Species in NK Cell-Mediated Control of Murine Melanoma Metastasis. Cancer Immunol Res. 2017;5:804–811.
   PubMed Web of Science ®Google Scholar
• Antony S, Jiang G, Wu Y, et al. NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27kip1 expression in malignant melanoma and other human tumors. Mol Carcinog. 2017;56:2643–2662.
   PubMed Web of Science ®Google Scholar
• Swick RW, Baumann CA, Miller WL, et al. Tocopherol in tumor tissues and effects of tocopherol on the development of liver tumors. Cancer Res. 1951;11:948–953.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhu H, Huang J, et al. The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia. Leuk Res. 2018;66:1–7.
   PubMed Web of Science ®Google Scholar
• Jaakkola K, Lähteenmäki P, Laakso J, et al. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res. 1992;12:599–606.
   PubMed Web of Science ®Google Scholar
• Satoh M, Naganuma A, Imura N. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice. Cancer Chemother Pharmacol. 1992;30:439–443.
   PubMed Web of Science ®Google Scholar
• Azmanova M, Pitto-Barry A. Oxidative Stress in Cancer Therapy: friend or Enemy? Chembiochem Eur J Chem Biol. 2022;23:e202100641.
   PubMed Web of Science ®Google Scholar
• Falone S, Santini S, Cordone V, et al. Extremely low-frequency magnetic fields and redox-responsive pathways linked to cancer drug resistance: insights from co-exposure-based in vitro studies. Front Public Health. 2018;6:33.
   PubMed Web of Science ®Google Scholar
• Hempel N, Carrico PM, Melendez JA. Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis. Anticancer Agents Med Chem. 2011;11:191–201.
   PubMed Web of Science ®Google Scholar
• Wu S, Lu H, Bai Y. Nrf2 in cancers: a double-edged sword. Cancer Med. 2019;8:2252–2267.
   PubMed Web of Science ®Google Scholar
• Ikehata H, Yamamoto M. Roles of the KEAP1-NRF2 system in mammalian skin exposed to UV radiation. Toxicol Appl Pharmacol. 2018;360:69–77.
   PubMed Web of Science ®Google Scholar
• Xian D, Lai R, Song J, et al. Emerging Perspective: role of Increased ROS and Redox Imbalance in Skin Carcinogenesis. Oxid Med Cell Longev. 2019;2019:8127362.
   PubMed Web of Science ®Google Scholar
• Falone S, Santini S, Cordone V, et al. Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox-related mechanisms. Sci Rep. 2017;7:11470.
   PubMed Web of Science ®Google Scholar
• Chern Y-J, Tai IT. Adaptive response of resistant cancer cells to chemotherapy. Cancer Biol Med. 2020;17:842–863.
   PubMed Web of Science ®Google Scholar
• Holohan C, Van Schaeybroeck S, Longley DB, et al. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13:714–726.
   PubMed Web of Science ®Google Scholar
• Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol. 2005;205:275–292.
   PubMed Web of Science ®Google Scholar
• Debatin K-M, Krammer PH. Death receptors in chemotherapy and cancer. Oncogene. 2004;23:2950–2966.
   PubMed Web of Science ®Google Scholar
• Tirichen H, Yaigoub H, Xu W, et al. Mitochondrial Reactive Oxygen Species and Their Contribution in Chronic Kidney Disease Progression Through Oxidative Stress. Front physiol. 2021;12:627837.
   PubMed Web of Science ®Google Scholar
• Zhuang C, Zhuang C, Luo X, et al. N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis. J Cell Mol Med. 2019;23:2163–2173.
   PubMed Web of Science ®Google Scholar
• Mauer J, Sindelar M, Despic V, et al. FTO controls reversible m6am RNA methylation during snRNA biogenesis. Nat Chem Biol. 2019;15:340–347.
   PubMed Web of Science ®Google Scholar
• Mauer J, Luo X, Blanjoie A, et al. Reversible methylation of m6am in the 5’ cap controls mRNA stability. Nature. 2017;541:371–375.
   PubMed Web of Science ®Google Scholar
• Chen X, Yu C, Guo M, et al. Down-Regulation of m6a mRNA Methylation is Involved in Dopaminergic Neuronal Death. ACS Chem Neurosci. 2019;10:2355–2363.
   PubMed Web of Science ®Google Scholar
• Liu X, Gonzalez G, Dai X, et al. Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m6a-Based Epitranscriptomic Mechanism. Mol Ther. 2020;28:2593–2604.
   PubMed Web of Science ®Google Scholar
• Lv Y, Li T, Yang M, et al. Melatonin Attenuates Chromium (VI)-Induced Spermatogonial Stem Cell/Progenitor Mitophagy by Restoration of METTL3-Mediated RNA N6-Methyladenosine Modification. Front Cell Dev Biol. 2021;9:684398.
   PubMed Web of Science ®Google Scholar
• Sun R, Tian X, Li Y, et al. The m6a reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. Redox Biol. 2022;54:102378.
   PubMed Web of Science ®Google Scholar
• Xu W, Lai Y, Pan Y, et al. M6a RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer. Cell Death Dis. 2022;13:715.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li X, Jia H, et al. The m6a methyltransferase METTL3 modifies PGC-1α mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes. J Biol Chem. 2021;297:101058.
   PubMed Web of Science ®Google Scholar
• Goffart S, Wiesner RJ. Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis. Exp Physiol. 2003;88:33–40.
   PubMed Web of Science ®Google Scholar
• Yang B, Chen Q .Cross-Talk between Oxidative Stress and m6a RNA Methylation in Cancer. Oxid Med Cell Longev. 2021:6545728. 2021. doi:10.1155/2021/6545728.
   PubMedGoogle Scholar
• Cory JG, Breland JC, Carter GL. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells. Cancer Res. 1979;39:4905–4913.
   PubMed Web of Science ®Google Scholar
• Chun K-S, Joo SH. Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance. Biomol Ther. 2022. DOI:10.4062/biomolther.2022.017
   Web of Science ®Google Scholar
• Adhikari S, Bhattacharya A, Adhikary S, et al. The paradigm of drug resistance in cancer: an epigenetic perspective. Biosci Rep. 2022;42:BSR20211812.
   PubMed Web of Science ®Google Scholar
• Stein-O’Brien G, Kagohara LT, Li S, et al. Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance. Genome Med. 2018;10:37.
   PubMed Web of Science ®Google Scholar
• Gustavsson M, Ronne H. Evidence that tRNA modifying enzymes are important in vivo targets for 5-fluorouracil in yeast. RNA N Y N. 2008;14:666–674.
   PubMed Web of Science ®Google Scholar
• Kouloulias V, Plataniotis G, Kouvaris J, et al. Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol. 2005;28:91–99.
   PubMed Web of Science ®Google Scholar
• Okamoto M, Fujiwara M, Hori M, et al. tRNA Modifying Enzymes, NSUN2 and METTL1, Determine Sensitivity to 5-Fluorouracil in HeLa Cells. In: Horwitz M, editor. PLoS Genet. Vol. 10. 2014. p. e1004639.
   Google Scholar
• Saikia M, Krokowski D, Guan B-J, et al. Genome-wide Identification and Quantitative Analysis of Cleaved tRNA Fragments Induced by Cellular Stress. J Biol Chem. 2012;287:42708–42725.
   PubMed Web of Science ®Google Scholar
• Elkordy A, Mishima E, Niizuma K, et al. Stress‐induced tRNA cleavage and tiRNA generation in rat neuronal PC12 cells. J Neurochem. 2018;146:560–569.
   PubMed Web of Science ®Google Scholar
• Pereira M, Ribeiro DR, Pinheiro MM, et al. M5u54 tRNA Hypomodification by Lack of TRMT2A Drives the Generation of tRNA-Derived Small RNAs. Int J Mol Sci. 2021;22:2941.
   PubMed Web of Science ®Google Scholar
• Taketo K, Konno M, Asai A, et al. The epitranscriptome m6a writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. Int J Oncol [Internet]. 2017 [cited 2022 Jun 23]; Available from: http://www.spandidos-publications.com/10.3892/ijo.2017.4219.
   Google Scholar
• Mantovani F, Collavin L, Del Sal G. Mutant p53 as a guardian of the cancer cell. Cell Death Differ. 2019;26:199–212.
   PubMed Web of Science ®Google Scholar
• Uddin MB, Roy KR, Hosain SB, et al. An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells. Biochem Pharmacol. 2019;160:134–145.
   PubMed Web of Science ®Google Scholar
• Liu D, Xu Y. P53, oxidative stress, and aging. Antioxid Redox Signal. 2011;15:1669–1678.
   PubMed Web of Science ®Google Scholar
• Ke W, Zhang L, Zhao X, et al. P53 m6a modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis. Apoptosis. 2022;27:426–440.
   PubMed Web of Science ®Google Scholar
• Y-N M, Hong Y-G, G-Y Y, et al. LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance. Cancer Cell Int. 2021;21:501.
   PubMed Web of Science ®Google Scholar
• Pan S, Deng Y, Fu J, et al. N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer. Int J Oncol. 2022;60:14.
   PubMed Web of Science ®Google Scholar
• Venugopal V, Sumi S. Molecular Biomarkers and Drug Targets in Brain Arteriovenous and Cavernous Malformations: where are We? Stroke. 2022;53:279–289.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X, Li H, et al. Antidepressant-like effects of helicid on a chronic unpredictable mild stress-induced depression rat model: inhibiting the IKK/IκBα/NF-κB pathway through NCALD to reduce inflammation. Int Immunopharmacol. 2021;93:107165.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li C, Guan C, et al. MiR-181d-5p Targets KLF6 to Improve Ischemia/Reperfusion-Induced AKI Through Effects on Renal Function, Apoptosis, and Inflammation. Front physiol. 2020;11:510.
   PubMed Web of Science ®Google Scholar
• Abdellateif MS, Salem SE, Badr DM, et al. The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients. J Inflamm Res. 2020;13:1245–1259.
   PubMed Web of Science ®Google Scholar
• D-X H, X-T G, Y-R L, et al. Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNac N -deacetylase/N -sulfotransferase-1 in human breast cancer. FEBS J. 2014;281:4718–4730.
   PubMed Web of Science ®Google Scholar
• Pecoraro M, Pala B, Di Marcantonio M, et al. Doxorubicin‑induced oxidative and nitrosative stress: mitochondrial connexin 43 is at the crossroads. Int J Mol Med. 2020;46:1197–1209.
   PubMed Web of Science ®Google Scholar
• Pilco-Ferreto N, Calaf GM. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. Int J Oncol. 2016;49:753–762.
   PubMed Web of Science ®Google Scholar
• Li P, Shan J-X, Chen X-H, et al. Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment. Cell Res. 2015;25:588–603.
   PubMed Web of Science ®Google Scholar
• Shi T, Dansen TB. Reactive Oxygen Species Induced p53 Activation: dNA Damage, Redox Signaling, or Both? Antioxid Redox Signal. 2020;33:839–859.
   PubMed Web of Science ®Google Scholar
• Pan X, Hong X, Li S, et al. METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6a-dependent manner. Exp Mol Med. 2021;53:91–102.
   PubMed Web of Science ®Google Scholar
• Dang X, Zhang R, Peng Z, et al. HIPK2 overexpression relieves hypoxia/reoxygenation-induced apoptosis and oxidative damage of cardiomyocytes through enhancement of the Nrf2/ARE signaling pathway. Chem Biol Interact. 2020;316:108922.
   PubMed Web of Science ®Google Scholar
• Yu W, Chen Y, Dubrulle J, et al. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci Rep. 2018;8:4306.
   PubMed Web of Science ®Google Scholar
• He P, Ge R, Mao W, et al. Oxidative stress induced by carboplatin promotes apoptosis and inhibits migration of HN‑3 cells. Oncol Lett [Internet]. 2018 [cited 2022 Jun 23]; Available from: http://www.spandidos-publications.com/10.3892/ol.2018.9563.
   Google Scholar
• Dhillon AS, Hagan S, Rath O, et al. MAP kinase signalling pathways in cancer. Oncogene. 2007;26:3279–3290.
   PubMed Web of Science ®Google Scholar
• Corre I, Paris F, Huot J. The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells. Oncotarget. 2017;8:55684–55714.
   PubMedGoogle Scholar
• Li Y, Li J, Luo M, et al. Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma. Cancer Lett. 2018;430:57–66.
   PubMed Web of Science ®Google Scholar
• Jin D, Guo J, Wu Y, et al. M6a mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J Hematol OncolJ Hematol Oncol. 2019;12:135.
   PubMed Web of Science ®Google Scholar
• Zanconato F, Cordenonsi M, Piccolo S. YAP/TAZ at the Roots of Cancer. Cancer Cell. 2016;29:783–803.
   PubMed Web of Science ®Google Scholar
• Grattarola M, Cucci MA, Roetto A, et al. Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells. Free Radic Biol Med. 2021;174:202–210.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kang M, Zhang B, et al. M6a modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5. Mol Cancer. 2019;18:185.
   PubMed Web of Science ®Google Scholar
• Teng B-W, Zhang K-D, Yang Y-H, et al. Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis. World J Gastrointest Oncol. 2021;13:1709–1724.
   PubMed Web of Science ®Google Scholar
• Wei J, Yin Y, Zhou J, et al. METTL3 potentiates resistance to cisplatin through m 6 a modification of TFAP2C in seminoma. J Cell Mol Med. 2020;24:11366–11380.
   PubMed Web of Science ®Google Scholar
• Kulak MV, Cyr AR, Woodfield GW, et al. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer. Oncogene. 2013;32:4043–4051.
   PubMed Web of Science ®Google Scholar
• Song Z, Jia G, Ma P, et al. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6a modification-mediated ferroptosis. Life Sci. 2021;276:119399.
   PubMed Web of Science ®Google Scholar
• Guo J, Xu B, Han Q, et al. Ferroptosis: a Novel Anti-tumor Action for Cisplatin. Cancer Res Treat. 2018;50:445–460.
   PubMed Web of Science ®Google Scholar
• Sun S, Gao T, Pang B, et al. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6a-dependent manner. Cell Death Dis. 2022;13:73.
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu X, Jin S, et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21:47.
   PubMed Web of Science ®Google Scholar
• Nie Q, Hu Y, Yu X, et al. Induction and application of ferroptosis in cancer therapy. Cancer Cell Int. 2022;22:12.
   PubMed Web of Science ®Google Scholar
• Christman JK. 5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21:5483–5495.
   PubMed Web of Science ®Google Scholar
• Cheng JX, Chen L, Li Y, et al. RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 2018;9:1163.
   PubMed Web of Science ®Google Scholar
• Gkatza NA, Castro C, Harvey RF, et al. Cytosine-5 RNA methylation links protein synthesis to cell metabolism. PLoS Biol. 2019;17:e3000297.
   PubMed Web of Science ®Google Scholar
• Lewinska A, Adamczyk-Grochala J, Kwasniewicz E, et al. Reduced levels of methyltransferase DNMT2 sensitize human fibroblasts to oxidative stress and DNA damage that is accompanied by changes in proliferation-related miRNA expression. Redox Biol. 2018;14:20–34.
   PubMed Web of Science ®Google Scholar
• Hou D, Liu Z, Xu X, et al. Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer. Redox Biol. 2018;17:99–111.
   PubMed Web of Science ®Google Scholar
• Fukumoto T, Zhu H, Nacarelli T, et al. N6-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance. Cancer Res. 2019;79:2812–2820.
   PubMed Web of Science ®Google Scholar
• Wang Z, Xia J, Li J, et al. Rg1 Protects Hematopoietic Stem Cells from LiCl-Induced Oxidative Stress via Wnt Signaling Pathway. Evid-Based Complement Altern Med ECAM. 2022;2022:2875583.
   PubMed Web of Science ®Google Scholar
• Majchrzak-Celińska A, Kleszcz R, Studzińska-Sroka E, et al. Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide. Cells. 2022;11:1084.
   PubMed Web of Science ®Google Scholar
• Cong K, Cantor SB. Exploiting replication gaps for cancer therapy. Mol Cell. 2022;82:2363–2369.
   PubMed Web of Science ®Google Scholar
• Balko JM, Potti A, Saunders C, et al. Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors. BMC Genomics. 2006;7:289.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Hernández MA, de la Cruz-Ojeda P, Gallego P, et al. Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells. Biochem Pharmacol. 2020;176:113902.
   PubMed Web of Science ®Google Scholar
• Lin Z, Niu Y, Wan A, et al. RNA m 6 a methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy. EMBO J. 2020;39 [[cited 2022 Jul 1]]. InternetAvailable from: https://onlinelibrary.wiley.com/doi/10.15252/embj.2019103181
   Web of Science ®Google Scholar
• Essers MAG, de Vries-Smits LMM, Barker N, et al. Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling. Science. 2005;308:1181–1184.
   PubMed Web of Science ®Google Scholar
• Burgering BMT, Medema RH. Decisions on life and death: fOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukocyte Biol. 2003;73:689–701.
   PubMed Web of Science ®Google Scholar
• Di Emidio G, Falone S, Vitti M, et al. SIRT1 signalling protects mouse oocytes against oxidative stress and is deregulated during aging. Hum Reprod Oxf Eng. 2014;29:2006–2017.
   PubMed Web of Science ®Google Scholar
• Okon IS, Coughlan KA, Zhang M, et al. Gefitinib-mediated reactive oxygen specie (ROS) instigates mitochondrial dysfunction and drug resistance in lung cancer cells. J Biol Chem. 2015;290:9101–9110.
   PubMed Web of Science ®Google Scholar
• Liu S, Li Q, Li G, et al. The mechanism of m6a methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene. Cell Death Dis. 2020;11:969.
   PubMed Web of Science ®Google Scholar
• Chen H, Jia B, Zhang Q, et al. Meclofenamic Acid Restores Gefinitib Sensitivity by Downregulating Breast Cancer Resistance Protein and Multidrug Resistance Protein 7 via FTO/m6A-Demethylation/c-Myc in Non-Small Cell Lung Cancer. Front Oncol. 2022;12:870636.
   PubMed Web of Science ®Google Scholar
• Marengo B, Garbarino O, Speciale A, et al. MYC Expression and Metabolic Redox Changes in Cancer Cells: a Synergy Able to Induce Chemoresistance. Oxid Med Cell Longev. 2019;2019:1–9.
   Web of Science ®Google Scholar
• Wang KC, Chang HY. Molecular Mechanisms of Long Noncoding RNAs. Mol Cell. 2011;43:904–914.
   PubMed Web of Science ®Google Scholar
• Yan X, Hu Z, Feng Y, et al. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 2015;28:529–540.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xiang D, Zhao X, et al. Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m6a methylation promotes disease progression and sorafenib resistance. Hum Cell. 2021;34:1800–1811.
   PubMed Web of Science ®Google Scholar
• Singh AK, Kashyap MP, Tripathi VK, et al. Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats. Mol Neurobiol. 2017;54:5815–5828.
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Shang YC, Hou J, et al. Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways. Oxid Med Cell Longev. 2010;3:153–165.
   PubMed Web of Science ®Google Scholar
• Quirke VM. Tamoxifen from Failed Contraceptive Pill to Best-Selling Breast Cancer Medicine: a Case-Study in Pharmaceutical Innovation. Front Pharmacol. 2017;8:620.
   PubMed Web of Science ®Google Scholar
• Bekele RT, Venkatraman G, Liu R-Z, et al. Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance. Sci Rep. 2016;6:21164.
   PubMed Web of Science ®Google Scholar
• Panayiotou C, Solaroli N, Karlsson A. The many isoforms of human adenylate kinases. Int J Biochem Cell Biol. 2014;49:75–83.
   PubMed Web of Science ®Google Scholar
• Jan Y-H, Lai T-C, Yang C-J, et al. Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis. J Hematol OncolJ Hematol Oncol. 2019;12:12.
   PubMed Web of Science ®Google Scholar
• Shan Y, Akram A, Amatullah H, et al. ATF3 protects pulmonary resident cells from acute and ventilator-induced lung injury by preventing Nrf2 degradation. Antioxid Redox Signal. 2015;22:651–668.
   PubMed Web of Science ®Google Scholar
• Liu X, Yuan J, Zhang X, et al. ATF3 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an N 6 -Methyladenosine-Based Epitranscriptomic Mechanism. Chem Res Toxicol. 2021;34:1814–1821.
   PubMed Web of Science ®Google Scholar
• Edagawa M, Kawauchi J, Hirata M, et al. Role of Activating Transcription Factor 3 (ATF3) in Endoplasmic Reticulum (ER) Stress-induced Sensitization of p53-deficient Human Colon Cancer Cells to Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis through Up-regulation of Death Receptor 5 (DR5) by Zerumbone and Celecoxib. J Biol Chem. 2014;289:21544–21561.
   PubMed Web of Science ®Google Scholar
• Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal. 2007;9:2277–2293.
   PubMed Web of Science ®Google Scholar
• Higa A, Chevet E. Redox signaling loops in the unfolded protein response. Cell Signal. 2012;24:1548–1555.
   PubMed Web of Science ®Google Scholar
• Hourihan JM, Moronetti Mazzeo LE, Fernández-Cárdenas LP, et al. Cysteine Sulfenylation Directs IRE-1 to Activate the SKN-1/nrf2 Antioxidant Response. Mol Cell. 2016;63:553–566.
   PubMed Web of Science ®Google Scholar
• Gordon RR, Nelson PS. Cellular senescence and cancer chemotherapy resistance. Drug Resist Updat. 2012;15:123–131.
   PubMed Web of Science ®Google Scholar
• Brunner TB. The rationale of combined radiotherapy and chemotherapy - Joint action of Castor and Pollux. Best Pract Res Clin Gastroenterol. 2016;30:515–528.
   PubMed Web of Science ®Google Scholar
• Navarro J, Obrador E, Pellicer JA, et al. Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radic Biol Med. 1997;22:1203–1209.
   PubMed Web of Science ®Google Scholar
• Jia S, Dong S, Liu H, et al. Dopamine-derived nanoparticles for the protection of irradiation-induced intestinal injury by maintaining intestinal homeostasis. Biomater Sci. 2022;10:3309–3322.
   PubMed Web of Science ®Google Scholar
• Kowalski-Chauvel A, Lacore MG, Arnauduc F, et al. The m6a RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells. Cancers (Basel). 2020;13:40.
   PubMed Web of Science ®Google Scholar
• Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23:1124–1134.
   PubMed Web of Science ®Google Scholar
• Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol. 2019;234:8381–8395.
   PubMed Web of Science ®Google Scholar
• Shibue T, Weinberg RE. Cscs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611–629.
   PubMed Web of Science ®Google Scholar
• Talukdar S, Emdad L, Das SK, et al. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells. Adv Cancer Res [Internet] Elsevier ; 2016 [cited 2022 Jul 6]. p. 159–191. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0065230X16300343.
   Google Scholar
• Jiang Q, Crews LA, Holm F, et al. RNA editing-dependent epitranscriptome diversity in cancer stem cells. Nat Rev Cancer. 2017;17:381–392.
   PubMed Web of Science ®Google Scholar
• Lin S, Choe J, Du P, et al. The m(6)a Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. Mol Cell. 2016;62:335–345.
   PubMed Web of Science ®Google Scholar
• Gao Q, Zheng J, Ni Z, et al. The m6a Methylation-Regulated AFF4 Promotes Self-Renewal of Bladder Cancer Stem Cells. Stem Cells Int. 2020;2020:8849218.
   PubMed Web of Science ®Google Scholar
• Shriwas O, Priyadarshini M, Samal SK, et al. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6a-demethylation of FOXM1 and NANOG. Apoptosis Int J Program Cell Death. 2020;25:233–246.
   PubMed Web of Science ®Google Scholar
• Mohan A, R RR, Mohan G, et al. Reporters of Cancer Stem Cells as a Tool for Drug Discovery. Front Oncol. 2021;11:669250.
   PubMedGoogle Scholar
• Tsao A-N, Chuang Y-S, Lin Y-C, et al. Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway. Oncol Rep. 2022;47:105.
   PubMed Web of Science ®Google Scholar
• Li L, Liu Y, Xiao L-M, et al. Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activated FOXM1/AGR2/HIF-1α axis. Lab Investig J Tech Methods Pathol. 2022;102:691–701.
   PubMed Web of Science ®Google Scholar
• Song I-S, Jeong YJ, Jeong SH, et al. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function. Gastroenterology. 2015;149:1006–1016.e9.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wu J, Liu F, et al. IGF2BP1 Promotes the Liver Cancer Stem Cell Phenotype by Regulating MGAT5 mRNA Stability by m6a RNA Methylation. Stem Cells Dev. 2021. scd.2021.0153. 10.1089/scd.2021.0153
   Web of Science ®Google Scholar
• Wang Y, Wang J, Li X, et al. N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism. Nat Commun. 2021;12:6314.
   PubMed Web of Science ®Google Scholar
• Sari IN, Phi LTH, Jun N, et al. Hedgehog Signaling in Cancer: a Prospective Therapeutic Target for Eradicating Cancer Stem Cells. Cells. 2018;7:E208.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang Z, Yang Q, et al. RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53. Front Oncol. 2022;12:858694.
   PubMed Web of Science ®Google Scholar
• Oiseth SJ, Aziz MS. Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead. J Cancer Metastasis Treat. 2017;3:250.
   Google Scholar
• Chow MT, Möller A, Smyth MJ. Inflammation and immune surveillance in cancer. Semin Cancer Biol. 2012;22:23–32.
   PubMed Web of Science ®Google Scholar
• Halliday GM, Patel A, Hunt MJ, et al. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J Surg. 1995;19:352–358.
   PubMed Web of Science ®Google Scholar
• Li N, Kang Y, Wang L, et al. ALKBH5 regulates anti–pd-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci. 2020;117:20159–20170.
   PubMed Web of Science ®Google Scholar
• Zhang F, Huang H, Qin Y, et al. MTDH associates with m6a RNA methylation and predicts cancer response for immune checkpoint treatment. iScience. 2021;24:103102.
   PubMed Web of Science ®Google Scholar
• Emdad L, Das SK, Hu B, et al. AEG-1/MTDH/LYRIC: a Promiscuous Protein Partner Critical in Cancer, Obesity, and CNS Diseases. Adv Cancer Res. 2016;131:97–132.
   PubMed Web of Science ®Google Scholar
• Yu C, Liu Y, Tan H, et al. Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial–mesenchymal transition. Cancer Lett. 2014;343:258–267.
   PubMed Web of Science ®Google Scholar
• Yin H, Zhang X, Yang P, et al. RNA m6a methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394.
   PubMed Web of Science ®Google Scholar
• Hayakawa T, Sugiyama J, Yaguchi T, et al. Enhanced anti-tumor effects of the PD-1/PD-L1 blockade by combining a highly absorptive form of NF-kB/STAT3 inhibitor curcumin. J Immunother Cancer. 2014;2:P210. 2051-1426-2-S3-P210.
   Google Scholar
• Liu Z, Wang T, She Y, et al. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20:105.
   PubMed Web of Science ®Google Scholar
• Aventaggiato M, Vernucci E, Barreca F, et al. Sirtuins’ control of autophagy and mitophagy in cancer. Pharmacol Ther. 2021;221:107748.
   PubMed Web of Science ®Google Scholar
• Lu Z, Liu H, Song N, et al. METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1. Cell Death Dis. 2021;12:881.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen W. Emerging Roles of SIRT1 in Cancer Drug Resistance. Genes Cancer. 2013;4:82–90.
   PubMedGoogle Scholar
• Luo J, Nikolaev AY, Imai S, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001;107:137–148.
   PubMed Web of Science ®Google Scholar
• Dai JM, Wang ZY, Sun DC, et al. SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity. J Cell Physiol. 2007;210:161–166.
   PubMed Web of Science ®Google Scholar
• O’Hagan HM, Mohammad HP, Baylin SB. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet. 2008;4:e1000155.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ren D, Fedorova J, et al. SIRT1/SIRT3 Modulates Redox Homeostasis during Ischemia/Reperfusion in the Aging Heart. Antioxid Basel Switz. 2020;9:E858.
   PubMed Web of Science ®Google Scholar
• Falone S, Santini S, di Loreto S, et al. Improved mitochondrial and methylglyoxal-related metabolisms support hyperproliferation induced by 50 Hz magnetic field in neuroblastoma cells. J Cell Physiol. 2016;231:2014–2025.
   PubMed Web of Science ®Google Scholar
• Thornalley PJ. Protecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherapy. Biochem Soc Trans. 2003;31:1372–1377.
   PubMed Web of Science ®Google Scholar
• Rabbani N, Xue M, Weickert MO, et al. Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology—involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy. Semin Cancer Biol. 2018;49:83–93.
   PubMed Web of Science ®Google Scholar
• Honek JF. Glyoxalase biochemistry. Biomol Concepts. 2015;6:401–414.
   PubMedGoogle Scholar
• Sakamoto H, Mashima T, Kizaki A, et al. Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood. 2000;95:3214–3218.
   PubMed Web of Science ®Google Scholar
• Antognelli C, Palumbo I, Aristei C, et al. Glyoxalase I inhibition induces apoptosis in irradiated MCF-7 cells via a novel mechanism involving Hsp27, p53 and NF-κB. Br J Cancer. 2014;111:395–406.
   PubMed Web of Science ®Google Scholar
• Michel M, Hollenbach M, Pohl S, et al. Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma. Front Oncol. 2019;9:785.
   PubMed Web of Science ®Google Scholar
• Kulkarni CA, Nadtochiy SM, Kennedy L, et al. ALKBH7 mediates necrosis via rewiring of glyoxal metabolism. Elife. 2020;9:e58573.
   PubMed Web of Science ®Google Scholar
• Marchand V, Pichot F, Thüring K, et al. Next‐generation Sequencing‐Based RiboMethseq Protocol for Analysis of tRNA 2′‐o‐methylation. Biomolecules. 2017;7:13.
   PubMed Web of Science ®Google Scholar
• Li X, Xiong X, Yi C. Epitranscriptome sequencing technologies: decoding RNA modifications. Nat Methods. 2016;14:23–31.
   PubMed Web of Science ®Google Scholar
• Kong Y, Hu H, Shan Y, et al. Accurate quantification of 3′-terminal 2′-O-methylated small RNAs by utilizing oxidative deep sequencing and stem-loop RT-qPCR. Front Med. 2022;16:240–250.
   PubMed Web of Science ®Google Scholar
• Cui J, Liu Q, Sendinc E, et al. Nucleotide resolution profiling of m3c RNA modification by HAC-seq. Nucleic Acids Res. 2021;49: e27–e27.
   Web of Science ®Google Scholar
• Amalric A, Bastide A, Attina A, et al. Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology. Crit Rev Clin Lab Sci. 2022;59:1–18.
   PubMed Web of Science ®Google Scholar
• Cui X, Zhou Y, Zheng Y, et al. Investigation of the enhanced photoactivity of CdS/Bi2MoO6/MoSe2 and its application in antibody-free enzyme-assisted photoelectrochemical strategy for detection of N6-methyladenosine and FTO protein. Mater Today Nano. 2022;20:100269.
   Google Scholar
• Kourou K, Exarchos TP, Exarchos KP, et al. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8–17.
   PubMed Web of Science ®Google Scholar
• Thomas A, Barriere S, Broseus L, et al. GECKO is a genetic algorithm to classify and explore high throughput sequencing data. Commun Biol. 2019;2:222.
   PubMed Web of Science ®Google Scholar
• Sui Q, Chen Z, Hu Z, et al. Cisplatin resistance-related multi-omics differences and the establishment of machine learning models. J Transl Med. 2022;20:171.
   PubMed Web of Science ®Google Scholar
• Nahar S, Kotikam V, Kumar VA, et al. Inhibition of miR-21 by 3′/5′-Serinyl-Capped 2′- O -Methyl RNA Interspersed with 2′- O -(2-Amino-3-Methoxypropyl) Uridine Units. Nucleic Acid Ther. 2016;26:327–334.
   PubMed Web of Science ®Google Scholar